ACTIVE LEARNING TEMPLATE: Medication
Megan Hale
STUDENT NAME _____________________________________
Dygoxin
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
21
Cardiac glycosides
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Increases the force of myocardial contraction. Prolongs Heart failure. Atrial fibrillation and atrial flutter
refractory period of the AV node. Decreases conduction
through the SA and AV nodes. Therapeutic Effects: (slows ventricular rate). Paroxysmal atrial
Increased cardiac output (positive inotropic effect) and tachycardia
slowing of the heart rate (negative chronotropic effect
Complications Medication Administration
CNS: fatigue, headache, weakness. EENT: blurred vision, yellow or IV (Adults): Digitalizing dose—0.5-1
green vision. CV: ARRHYTHMIAS, bradycardia, ECG changes, AV mg . PO (Adults): Digitalizing
block, SA block. GI: anorexia, *nausea, vomiting, diarrhea. Hemat: dose—0.75-1.5 mg given as 50% of
thrombocytopenia. Metab: electrolyte imbalances with acute digoxin the dose initially and one quarter of the
toxicity initial dose in each of 2 doses at 6-12
hr intervals. Maintenance
dose—0.125-0.5 mg/day depending
on pts lean body weight, renal
function, serum level..
Contraindications/Precautions
Hypokalemia greatly increase risk of digoxin toxicity
Hypercalcemia increase risk of toxicity, especially with
mild hypokalemia); Hypomagnesemia may increaserisk of Nursing Interventions
digoxin toxicity Monitor ECG during IV administration.
Notify professional if bradycardia or
new arrhythmias occur. Monitor intake
and output ratios and daily weights.
Assess for peripheral edema, and
auscultate lungs for rales or crackles
Interactions throughout therapy.. Digoxin increased
Digoxin & Lasix (furosemide)-Concurrent use of DIGOXIN risk of falls in the elderly
and LOOP DIURETICS may result in increased risk of
digoxin toxicity (nausea, vomiting, cardiac arrhythmias).
Digoxin & Micro-K- No interaction Digoxin & Cefotetan-
No interaction Digoxin & Hyrdomorphone- No interaction
Client Education
Instruct patient to take medication as directed, at the same time
each day. Teach parents or caregivers of infants and children
how to accurately measure medication. Take missed doses
within 12 hr of scheduled dose or omit. Do not double doses.
Evaluation of Medication Effectiveness Consult health care professional if doses for 2 or more days are
missed. Do not discontinue medication without consulting health
Decrease in severity of HF. ？ Increase in cardiac output. ？ care professional. ？ Teach patient to take pulse and to contact
health care professional before taking medication if pulse rate is
<60 or >100. ？ Pedi: Teach parents or caregivers that changes in
Decrease in ventricular response in atrial heart rate, especially bradycardia, are among the first signs of
tachyarrhythmias. ？ Termination of paroxysmal atrial digoxin toxicity in infants and children
tachycardia
ACTIVE LEARNING TEMPLATES TherapeuTic procedure A7
Megan Hale
STUDENT NAME _____________________________________
Dygoxin
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
21
Cardiac glycosides
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Increases the force of myocardial contraction. Prolongs Heart failure. Atrial fibrillation and atrial flutter
refractory period of the AV node. Decreases conduction
through the SA and AV nodes. Therapeutic Effects: (slows ventricular rate). Paroxysmal atrial
Increased cardiac output (positive inotropic effect) and tachycardia
slowing of the heart rate (negative chronotropic effect
Complications Medication Administration
CNS: fatigue, headache, weakness. EENT: blurred vision, yellow or IV (Adults): Digitalizing dose—0.5-1
green vision. CV: ARRHYTHMIAS, bradycardia, ECG changes, AV mg . PO (Adults): Digitalizing
block, SA block. GI: anorexia, *nausea, vomiting, diarrhea. Hemat: dose—0.75-1.5 mg given as 50% of
thrombocytopenia. Metab: electrolyte imbalances with acute digoxin the dose initially and one quarter of the
toxicity initial dose in each of 2 doses at 6-12
hr intervals. Maintenance
dose—0.125-0.5 mg/day depending
on pts lean body weight, renal
function, serum level..
Contraindications/Precautions
Hypokalemia greatly increase risk of digoxin toxicity
Hypercalcemia increase risk of toxicity, especially with
mild hypokalemia); Hypomagnesemia may increaserisk of Nursing Interventions
digoxin toxicity Monitor ECG during IV administration.
Notify professional if bradycardia or
new arrhythmias occur. Monitor intake
and output ratios and daily weights.
Assess for peripheral edema, and
auscultate lungs for rales or crackles
Interactions throughout therapy.. Digoxin increased
Digoxin & Lasix (furosemide)-Concurrent use of DIGOXIN risk of falls in the elderly
and LOOP DIURETICS may result in increased risk of
digoxin toxicity (nausea, vomiting, cardiac arrhythmias).
Digoxin & Micro-K- No interaction Digoxin & Cefotetan-
No interaction Digoxin & Hyrdomorphone- No interaction
Client Education
Instruct patient to take medication as directed, at the same time
each day. Teach parents or caregivers of infants and children
how to accurately measure medication. Take missed doses
within 12 hr of scheduled dose or omit. Do not double doses.
Evaluation of Medication Effectiveness Consult health care professional if doses for 2 or more days are
missed. Do not discontinue medication without consulting health
Decrease in severity of HF. ？ Increase in cardiac output. ？ care professional. ？ Teach patient to take pulse and to contact
health care professional before taking medication if pulse rate is
<60 or >100. ？ Pedi: Teach parents or caregivers that changes in
Decrease in ventricular response in atrial heart rate, especially bradycardia, are among the first signs of
tachyarrhythmias. ？ Termination of paroxysmal atrial digoxin toxicity in infants and children
tachycardia
ACTIVE LEARNING TEMPLATES TherapeuTic procedure A7
